Johnson & Johnson and Procter & Gamble: The Top Dividend Aristocrats for a 10-Year Hold

↕

  //stocks-investing.news-articles.net/content/202 .. top-dividend-aristocrats-for-a-10-year-hold.html
  Published in Stocks and Investing on Wednesday, December 10th 2025 at 4:40 GMT by The Motley Fool
      Locale: UNITED STATES

The 2 Best Dividend Stocks to Buy Now and Hold for a Decade – A 2025 Summary

On December 10, 2025, The Motley Fool released a timely, data‑driven recommendation for investors who want to build a solid, income‑generating portfolio that will weather the next ten years. The article, titled “The 2 Best Dividend Stocks to Buy Now and Hold for a Decade,” focuses on two blue‑chip stalwarts that have proven resilient, consistently rewarded shareholders with growing dividends, and are poised to keep delivering value even in a volatile economic environment. While the specific numbers are always subject to change, the underlying thesis and analytic framework remain evergreen.

1. The “Dividend Aristocrats” Framework

The author opens by explaining the concept of Dividend Aristocrats—companies that have increased their quarterly dividend for at least 25 consecutive years. These firms combine stability with disciplined capital allocation, which makes them a natural fit for long‑term income investors. A link in the article directs readers to the full list of current Aristocrats, offering a handy resource for those who want to explore beyond the two picks.

2. First Pick: Johnson & Johnson (JNJ)

Why JNJ?
- Track record: JNJ is a 50‑plus year dividend grower with 57 consecutive increases.
- Yield & growth: The stock trades at a 2.9% yield while the Dividend Growth Score (link to Fool’s proprietary metric) shows a compound growth rate of 13.4% over the past decade.
- Business mix: Its diversified product portfolio—pharmaceuticals, medical devices, and consumer health products—provides multiple revenue streams that help smooth earnings during economic downturns.
- Cash flow & capital allocation: JNJ generated $20 billion of free cash flow last year, and the company has a disciplined approach to share buybacks, which supports the stock price while paying dividends.

Macro‑risk considerations
- Regulatory headwinds: The article notes that drug approvals can lag, potentially tightening margins for the pharmaceutical arm.
- Pricing pressure: Global supply‑chain bottlenecks could increase the cost of raw materials, squeezing operating margins.

The Motley Fool article also links to a deeper dive on JNJ’s Dividend Discount Model analysis, which demonstrates a fair value estimate that comfortably exceeds the current trading price.

3. Second Pick: Procter & Gamble Co (PG)

Why PG?
- Track record: PG has a 64‑year dividend record, with 61 consecutive quarterly increases.
- Yield & growth: The current yield sits around 2.4%, but the Dividend Growth Score is an impressive 15.7% CAGR.
- Business resilience: PG’s portfolio of household staples—shampoo, laundry detergent, and over‑the‑counter health products—creates defensive exposure that often outperforms during recessions.
- Global footprint: PG’s presence in 70+ countries buffers against localized downturns.

Macro‑risk considerations
- Commodity costs: Rising prices for key raw materials (e.g., oils and chemicals) can erode margins.
- Currency risk: PG’s earnings are sensitive to fluctuations in the euro and other foreign currencies, which could impact the dividend payout in the U.S. dollar.

The article links to a comparative analysis of PG’s Free Cash Flow Yield versus its peers, illustrating how the stock remains undervalued relative to its peers while maintaining a robust dividend history.

4. The 10‑Year Holding Strategy

The Motley Fool article frames the two picks as part of a “Hold for a Decade” approach, citing studies that show compounding dividends can boost total returns by up to 40% over a long period. The writer suggests that investors simply purchase the stocks at the market price, set up automatic reinvestment of dividends, and then let the compounding take over.

The article also links to a helpful spreadsheet that models the projected portfolio performance over ten years, assuming a 5% reinvested return and the historical dividend growth rates of JNJ and PG.

5. How to Integrate the Picks into Your Portfolio

• Diversification: The author recommends combining JNJ and PG with a small allocation to a high‑yield REIT and a growth stock, maintaining a balanced risk‑return profile.
• Rebalancing: A semi‑annual review is advised to ensure the dividend yields remain attractive and that the companies continue to meet the Dividend Aristocrats criteria.
• Tax considerations: The article points to a link on the U.S. tax treatment of qualified dividends, reminding investors to account for state and federal taxes when calculating net returns.

6. Bottom Line

The Motley Fool’s December 2025 article delivers a concise, evidence‑based endorsement of Johnson & Johnson (JNJ) and Procter & Gamble (PG) as the two best dividend stocks to buy now and hold for a decade. Both companies boast long, unbroken dividend histories, solid cash flows, and diversified business models that can weather economic turbulence. While no investment is risk‑free—regulatory, commodity, and currency headwinds loom—the article presents a compelling case for their inclusion in any long‑term income portfolio.

For further reading, the article links to:

1. The full Dividend Aristocrats list (to explore other candidates).
2. A Dividend Discount Model calculator for JNJ and PG.
3. A Free Cash Flow Yield comparison across consumer staples.
4. The Fool’s guide on Tax‑efficient dividend investing.

These resources equip investors with the tools they need to dig deeper, perform their own due diligence, and confidently build a portfolio that delivers steady, growing income for at least the next ten years.